TNF and Erythema: Furthermore, in 3/16 (18.8%, 95% CI: 4.1–45.7%) patients receiving TNF-α inhibitors and in 0/32 (0%, 95% CI: 0–10.9%) controls the duration of erythema exceeded 100 days (p = 0.0324).